Literature DB >> 11792895

Etanercept and infliximab associated with cutaneous vasculitis.

M E McCain, R J Quinet, W E Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11792895     DOI： 10.1093/rheumatology/41.1.116

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  21 in total

Review 1.  Inflammatory mechanisms in cervicogenic headache: an integrative view.

Authors:  Paolo Martelletti
Journal:  Curr Pain Headache Rep       Date:  2002-08

Review 2.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

3.  Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment.

Authors:  Maria G Tektonidou; John Serelis; Fotini N Skopouli
Journal:  Clin Rheumatol       Date:  2006-07-06       Impact factor: 2.980

4.  Tumour necrosis factor alpha blockade and the risk of vasculitis.

Authors:  M De Bandt; B Saint-Marcoux
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

5.  Pustular skin lesions in patients treated with infliximab: report of two cases.

Authors:  M J F Starmans-Kool; H R M Peeters; H H M L Houben
Journal:  Rheumatol Int       Date:  2005-02-12       Impact factor: 2.631

6.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2002

Review 7.  Cutaneous vasculitis.

Authors:  Samina Hayat; Seth Mark Berney
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

Review 8.  New therapies for rheumatoid arthritis.

Authors:  F Goldblatt; D A Isenberg
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

9.  A case of cellulitis causing tissue defect during etanercept therapy.

Authors:  Dulgeroglu Deniz; Umay Ebru; Bal Ajda; Tetik Menevse Gulsum; Tatlican Semih; Cakci Aytul
Journal:  Rheumatol Int       Date:  2009-12-18       Impact factor: 2.631

Review 10.  Cervicogenic headache: practical approaches to therapy.

Authors:  Paolo Martelletti; Hans van Suijlekom
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.